What is Bayside Laboratories?
Established in 1968, Bayside Laboratories is a CLIA-certified laboratory operating in the New York Metro Area. The company provides a comprehensive suite of clinical testing services, including bacteriology, immunology, and toxicology. Bayside Laboratories serves healthcare providers, MedTech firms, and pharmaceutical companies, leveraging state-of-the-art technology to deliver fast, reliable next-day results. Its commitment to high-quality service and world-class customer support aims to enhance patient care.
How much funding has Bayside Laboratories raised?
Bayside Laboratories has raised a total of $335K across 2 funding rounds:
Debt
$150K
Debt
$185K
Debt (2020): $150K with participation from PPP
Debt (2021): $185K led by PPP
What's next for Bayside Laboratories?
With substantial late-stage funding and a recent strategic investment, Bayside Laboratories is poised for continued expansion and technological advancement. The company's focus on rapid, accurate diagnostic services, coupled with its long-standing reputation, positions it to capitalize on evolving healthcare demands. Future initiatives are likely to involve scaling operations, enhancing its service portfolio, and potentially exploring new market segments within the broader healthcare and life sciences industries.
See full Bayside Laboratories company page
